30.04.2026 • News

Ecolab Life Sciences Opens Bioprocessing Applications Lab in Korea to Support Downstream Process Development Across Asia

New facility serves biopharma manufacturers throughout the region with local access to customer purification studies across Ecolab's Purolite Resin portfolio

Researchers in the application lab
© Ecolab Life Sciences

Ecolab Life Sciences is expanding the bioprocessing business with the launch of a new Bioprocessing Applications Lab (BPAL) in Dongtan, Korea, giving biopharmaceutical manufacturers across Asia better local access to downstream process development support. Strategically located to serve customers throughout the region, the site is Ecolab's first bioprocessing facility in Asia and joins an established applications network in the United States and the United Kingdom.

BPAL Korea supports process development from early-stage resin screening through studies designed to replicate commercial manufacturing conditions. On-site scientists work alongside customers across Asia to help optimize chromatography steps, improve yield and productivity, and accelerate regulatory pathways, reducing the need to ship resins and reference materials overseas for development work.

Asia has become one of the world's most active biopharmaceutical manufacturing regions, with Korea, China, Japan, India, and Singapore all home to growing pipelines in biosimilars and monoclonal antibody processes that demand efficient, scalable downstream purification. With local technical support now in place, manufacturers across the region can shorten development cycles and maintain consistency with global operations while working to tight regulatory and cost targets.

"Biopharmaceutical manufacturers across Asia are under increasing pressure to scale with speed while meeting demanding regulatory and performance expectations," said Jenny Tan, VP and General Manager, Ecolab Life Sciences APAC and India. "BPAL Korea strengthens our ability to work side by side with customers, bringing deep local expertise together with Ecolab's global, integrated bioprocessing network."

By combining local scientific support with Ecolab’s innovative Purolite resin portfolio, Ecolab’s new BPAL helps enable manufacturers to address process challenges earlier, reduce development risk, and advance programs with greater confidence as they prepare for scale-up.

Company

Logo:

Ecolab Life Sciences

1 Ecolab Place
55102 St. Paul, MN
US

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.